• S&P 500: 1,351.95
  • Change: 0.00%
$16.54 0.00 (0%)
2/9/2012 4:00 PM

Omnicell, Inc. (NASDAQ:OMCL)

CAPS Rating: 3 out of 5

The Company is a provider of medication control and patient safety solutions for acute care health facilities.

Current Price $16.54 Mkt Cap $548.05M
Open $0.00 P/E Ratio 91.30
Prev. Close $16.54 Div. (Yield) N/A (N/A)
Daily Range $16.16 - $16.83 Volume 117,440
52-Wk Range $12.92 - $18.15 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think OMCL will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

161 Outperform
10 Underperform
 

All-Star Players

53 Outperform
4 Underperform
 

Wall Street

4 Outperform
2 Underperform
 

Top OMCL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

pegburt (67.01)
Submitted May 06, 2008

yea, the owner of this company has like 9 kids. he's pretty cool. i think this a good company. seanmcb doesn't know s h i t. he's my 13 year old brother

Add Comment | Reply | Report this Post

CrankyTexan (94.94)
Submitted October 18, 2007

I am a registered nurse who has used Omnicell machines. I hate them. In my opinion, they are a pain in the butt and they slow down my job. When I am rushing to get an item during surgery, the last thing I want to do is swipe my I.D. card, swipe the… More

7 Comments | Reply | Report this Post
OMCL VS S&P 500 (SPY)

Fools bullish on OMCL are also bullish on:

Fools bearish on OMCL are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about OMCL.

Recs

0
Member Avatar jimbendt (79.75) Submitted: 4/10/2010 2:42:37 AM : Outperform Start Price: $13.96 OMCL Score: +5.40

Can OMCL flourish in a super managed care environment?

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar Kinzo (99.33) Submitted: 4/3/2009 4:33:15 PM : Outperform Start Price: $7.90 OMCL Score: +45.26

Finally a solution for a doctor's poor handwriting! Get it automated! In all seriousness however, my best friend's grandfather died after receiving the wrong medication while in the hospital. Having OMCL's medication-management products may have prevented such a terrible thing from happening.

Although they aren't the biggest player in the market (Pyxis is), they are still gobbling up market share since they are ahead of the technology curve. Also, by specializing in medication-management products only, this allows the entire company to focus on its product. Oh and requiring 12-18 month software upgrades is nice too (for additional recurring revenues).

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar megaking (< 20) Submitted: 11/21/2008 7:14:47 PM : Underperform Start Price: $9.70 OMCL Score: -0.99

Large healthcare providers have implemented capital spending freezes which will directly affect Omnicell over the near future and will take at least a couple of years to become remotely profitable. The mobil solution company they recently purchased has proven to to be a failed venture as the quality of the product is lacking and hurting the Omnicell brand.

Report this Post Add Comment | Reply | Permalink
View All 24 Pitches »

Leaderboard

Find the members with the highest scoring picks in OMCL.

Score Leader

Peterhaze

Peterhaze (63.96) Score: +62.33

The Score Leader is the player with the highest score across all their picks in OMCL.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
Peterhaze 63.96 1/22/2009 Outperform 3Y $7.27 +127.51% +65.18% +62.33 0 Comment
pocestnik 23.05 4/25/2008 Outperform NS $11.06 +49.55% +0.66% +48.88 0 Comment
issac25 87.50 4/24/2008 Outperform NS $11.04 +49.82% +0.94% +48.87 0 Comment
healthcareinvest 42.82 4/24/2008 Outperform 3M $11.06 +49.55% +2.28% +47.26 1 Comment
johncant < 20 4/28/2008 Outperform 3M $11.25 +47.02% +0.40% +46.62 1 Comment
ikludge < 20 4/28/2008 Outperform NS $11.25 +47.02% +0.40% +46.62 1 Comment
kasib12 < 20 4/22/2008 Outperform NS $11.15 +48.34% +1.89% +46.45 0 Comment
Kinzo 99.33 4/6/2009 Outperform 5Y $7.90 +109.37% +64.11% +45.26 1 Comment
junglegomezz 76.49 4/22/2008 Outperform 3M $11.35 +45.73% +1.72% +44.00 0 Comment
nahamit 34.70 4/22/2008 4/22/2008 Outperform 3W $11.37 +45.47% +1.75% +43.72 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackStifel 96.90 6/14/2011 Outperform NS $13.99 +18.23% +5.04% +13.19 0 Comment
TrackFBRCapitalM 84.41 9/23/2010 Underperform NS $11.98 +43.57% +15.46% -28.11 7/29/2011 @ $17.20 0 Comment
TrackAurigaUSA < 20 6/10/2010 Outperform NS $12.25 +35.02% +25.50% +9.52 0 Comment
TrackZacks 70.75 4/9/2010 Outperform 3M $13.94 +18.65% +13.22% +5.43 1 Comment
TrackCarisandCo 88.55 7/24/2009 Outperform NS $11.35 +45.73% +39.92% +5.81 0 Comment
TrackAurigaUSA < 20 5/1/2009 Outperform NS $10.00 +5.20% +25.34% -20.14 10/20/2009 @ $10.52 0 Comment
TrackBBTCapMkts 94.69 1/21/2009 Underperform NS $7.05 +134.61% +69.56% -65.05 0 Comment
TrackAurigaUSA < 20 1/21/2009 Underperform NS $6.41 +36.66% -2.76% -39.42 2/18/2009 @ $8.76 0 Comment
TrackAurigaUSA < 20 12/17/2008 Outperform NS $12.30 -47.89% -10.26% -37.63 1/21/2009 @ $6.41 0 Comment
TrackBBTCapMkts 94.69 2/8/2008 Outperform NS $18.28 -61.71% -39.13% -22.58 1/21/2009 @ $7.00 0 Comment
TrackCarisandCo 88.55 2/4/2008 Outperform NS $20.25 -62.96% -39.86% -23.10 1/30/2009 @ $7.50 0 Comment
TrackBBTCapMkts 94.69 7/20/2007 Outperform NS $23.95 +21.29% +0.65% +20.64 10/10/2007 @ $29.05 0 Comment
TrackBroadpointAmTech 90.21 10/30/2006 Outperform NS $18.55 -35.90% +0.16% -36.07 4/22/2008 @ $11.89 0 Comment
TrackMatrix 92.65 9/13/2006 Underperform NS $18.00 -8.11% +9.65% +17.76 0 Comment

Featured Broker Partners